Ultra-rush immunotherapy: tolerance and efficacy of an aqueous preparation of Hymenoptera venom

被引：0
|
作者：
Patella, V [1 ]
Florio, G. [1 ]
Di Pace, L. [1 ]
Palmieri, M. [1 ]
Oricchio, C. [2 ]
机构：
[1] Agropoli Hosp, ASL SALERNO, Div Allergy & Clin Immunol, Salerno, Italy
[2] Agropoli Hosp, ASL SALERNO, Unit Transfus Med, Salerno, Italy
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1066
引用
收藏
页码：407 / 407
页数：1
相关论文
共 50 条
  • [41] A novel Pru p 3 sublingual immunotherapy ultra-rush protocol
    Moura, A. L.
    Pereira, C.
    Regateiro, F. S.
    Azevedo, J.
    Todo Bom, A.
    Faria, E.
    Carrapatoso, I
    ALLERGY, 2019, 74 : 78 - 78
  • [42] Adverse events associated with rush Hymenoptera venom immunotherapy
    Westall, GP
    Thien, FCK
    Czarny, D
    O'Hehir, RE
    Douglass, JA
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (05) : 227 - 230
  • [43] Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity
    Moore, Alexandra
    Burrows, Amanda K.
    Rosenkrantz, Wayne S.
    Ghubash, Rudayna M.
    Hosgood, Giselle
    VETERINARY DERMATOLOGY, 2023, 34 (06) : 532 - 542
  • [44] The Anti-Inflammatory Pro-Resolution Lipoxin A4 Increases During Ultra-Rush Venom Immunotherapy
    Patella, Vincenzo
    Romano, Mario
    Cianci, Eleonora
    Saitta, Salvatore
    Lattanzio, Stefano
    Florio, Giovanni
    Gangemi, Sebastiano
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB24 - AB24
  • [45] Ultra-rush immunotherapy in vespid allergic patients with indolent systemic mastocytosis
    Bilo', M.
    Cinti, B.
    Brianzoni, M.
    Braschi, C.
    Bonifazi, F.
    ALLERGY, 2011, 66 : 435 - 435
  • [46] Hymenoptera venom allergy: characteristics, tolerance and efficacy of immunotherapy in the pediatric population
    Fiandor, Ana
    Belver, M. Teresa
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2009, 37 (03) : 109 - 110
  • [47] Immunotherapy in pediatric patients with respiratory allergy: ultra-rush induction scheme
    Luz, S.
    Geraldo Dias, J.
    Palma Carlos, S.
    Leiria Pinto, P.
    ALLERGY, 2011, 66 : 210 - 210
  • [48] Pre-treatment with omalizumab allows ultra-rush honey bee venom immunotherapy in patients with mast cell disease
    da Silva, E. N.
    Randall, K. L.
    ALLERGY, 2014, 69 : 398 - 399
  • [49] Tolerability and Safety of a 3-day Ultra-Rush Immunotherapy with Bee and Wasp Venom Allergy with internal Medical Comorbidities
    Bernkopf, K.
    Schmitt, J.
    Spornraft-Ragaller, P.
    Bauer, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 : 166 - 166
  • [50] Safety and Efficacy of VIT against Wasp Venom in Ultra-Rush Protocols in Patients Older Than 60 Years
    Bozek, Andrzej
    Winterstein, Janne
    Pawlowicz, Robert
    Poians, Ian
    Sadowska, Dominika
    Miodonska, Martyna
    Nittner-Marszalska, Marita
    VACCINES, 2024, 12 (05)
12345